4D Molecular Therapeutics grants 260,000 stock options and 157,600 RSUs to 13 new employees

FDMT•2026-10-16

4D Molecular Therapeutics granted 13 new non-executive employees options to purchase 260,000 common shares and 157,600 restricted stock units on October 13, 2026.

1. Employee awards

The awards were granted under the company’s amended 2025 Employment Inducement Award Plan.

4D Molecular Therapeutics grants 260,000 stock options and 157,600 RSUs to 13 new employees

1. Employee awards

Related News

Eaton announces publication of audit report

Foreign US Treasury holdings rise in August, but China cuts to 2008 low

Waterstone Financial director Derek Tyus resigns, effective Oct. 20

NatWest issues $1 billion in senior callable debt

Ambiq Micro president Sean Chihhsiang Chen reports disposal of $772,438.2176 in common shares